Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Xiangxue Pharmaceutical Co Ltd

+ Add to Watchlist

300147:CH

40.310 CNY 0.310 0.77%

As of 03:00:30 ET on 05/25/2015.

Snapshot for Xiangxue Pharmaceutical Co Ltd (300147)

Open: 39.000 Day's Range: 38.030 - 40.490 Volume: 13,208,682
Previous Close: 40.000 52wk Range: 15.150 - 43.500 1-Yr Rtn: +111.50%

Stock Chart for 300147

No chart data available.
  • 300147:CH 40.310
  • 1D
  • 1M
  • 1Y
40.000
Interactive 300147 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300147

Current P/E Ratio (ttm) 97.2464
Estimated P/E(12/2015) 71.9821
Relative P/E vs. SZ399006 0.8373
Earnings Per Share (CNY) (ttm) 0.4145
Est. EPS (CNY) (12/2015) 0.5600
Est. PEG Ratio -
Market Cap (M CNY) 20,540.90
Shares Outstanding (M) 509.57
30 Day Average Volume 19,427,270
Price/Book (mrq) 11.7788
Price/Sale (ttm) 12.7395
Dividend Indicated Gross Yield 0.33%
Cash Dividend (CNY) 0.1350
Dividend Ex-Date 05/22/2015
5 Year Dividend Growth -
Next Earnings Announcement 08/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300147

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 300147

Xiangxue Pharmaceutical Company Limited produces and sells modern Chinese medicine. The Company's main products include anti-viral oral supplements and Banlangen capsules.

Wang YonghuiChairman/PresidentZhang YingVice President
Wu JunVice PresidentCeng LunVice President
More Company Profile & Key Executives for 300147

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil